Clinical: Board-certified in radiation treatment for all cancer locations/types.
Research: The long-term goal of Dr. Koontz’s research is to minimize treatment-related side effects of radiotherapy. To that end she has a laboratory studying the mechanisms of radiation induced erectile dysfunction and testing interventions to treat and prevent this devastating side effect of radiotherapy. Her clinical research investigates optimizing prostate cancer treatment and utilizes collaborations with colleagues in surgery and psychiatry to pursue further understanding of how sexual dysfunction develops after radiotherapy and how to improve patient-provider interactions regarding the sexuality and intimacy consequences of cancer therapy.
Education and Training
- Residency Training, Radiation Oncology, Duke University School of Medicine, 2003 - 2007
- Internship, University of North Carolina, Chapel Hill, School of Medicine, 2002 - 3003
- M.D., Harvard University , 2002
- B.S., Allegheny College, 1998
- Trimodality Approach to Unfavorable Localized Prostate Cancer: a prospective trial of Neoadjuvant Pembrolizumab, ADT, and Prostate SBRT followed by Radical Prostatectomy
- A prospective, Phase 3, multi-center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA-7.3 (18F) PET ligand in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy
- Movember Foundation GAP6 project
- Therapeutic targeting of B7-H3 to reverse prostate cancer treatment resistance.
- Developing knowledge models to enable rapid learning in radiation therapy
- New therapeutic strategy in reversing radiation-induced erectile dysfunction with prostate cancer pa-tients
- Janssen Research AGreement